Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ADM Tronics Unlimited, Inc. (ADMT)
Northvale, NJ, US
ADM Tronics Unlimited, Inc. (ADMT), established in 1969 and headquartered in Northvale, New Jersey, is a company that develops, manufactures, and markets electronic solutions. Its products are primarily designed for non-invasive medical applications, though they also serve other industries, with sales reaching the United States, Australia, Asia, and Europe. The company structures its business across three main divisions: Electronics, Chemical, and Engineering. Within its Electronics segment, ADMT creates specialized devices essential for diagnosing and treating both humans and animals, alongside providing electronic control systems for spas and hot tubs. The Chemical division offers a broad spectrum of water-based products, including primers, adhesives, coatings, resins, and chemical additives. This segment also manufactures anti-static conductive paints, coatings, and related items. Furthermore, it produces water-based, adhesive topical formulations for maxillofacial prosthetic medical applications, as well as for professional makeup artistry, especially in film, television, and theatrical settings. Finally, the Engineering segment delivers extensive services encompassing research, development, and regulatory support. These services are vital for the design, development, and manufacturing of medical devices, various electronic systems, and other advanced technologies and products, including those related to medical electronic therapeutic technology.
Based on only 1 article — low confidence
- ADM Tronics Reports Fiscal Year 2026 Accesswire
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +16.67% | +14.75% | -12.50% | -30.00% | -41.67% | -30.00% | +17.25% | -30.00% | -50.00% | -65.00% | -89.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%+12.4% ★ Q4'25: +7.1% (vs Q4'24)
-
EPS growth Medical - Devices: +28.5%+83.2% ★ Q4'25: +51.4% (vs Q4'24)
-
FCF margin FCF growth · Medical - Devices: +30.9%-7.2% Q4'25: -2.4% (vs Q4'24)
-
EBIT margin Medical - Devices: +6.2%-2.5% Q4'25: -10.5% (vs Q4'24)
-
ROIC Medical - Devices: +3.3%-7.2% Q4'25: -24.6% (vs Q4'24)
-
Share dilution Medical - Devices: 0.0%+0.0% ★ Q4'25: +0.0% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×68.90× Q4'25: -3.80× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Steven Bayern | 3.15M | 5.30% | 150.0K | 3.00M | 3.15M | — | IN | USA | 2013-02-05 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | U S WEALTH GROUP, LLC. | 83.6K +— (+0.0%) | 8.4K +167.0 (+2.0%) | 0.12% +0.000 pp | 0.01% +0.000 pp | USD0.07 +42.9% | 5 qtrs — |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Andre' DiMino | President, Chief Executive Officer, Chief Financial Officer & Director | 108.4K | — |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ADMT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
